Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daidi Fu
Observed name:
D. Fu
Institution:
Central Hospital of Zibo
Observed institutions:
Shandong University,
Central Hospital of Zibo
ORCID:
0009-0005-2706-5538
Observed ORCID:
0009-0005-2706-5538
OpenAlex ID:
A5109276872
Randomized, Double-Blind, Placebo-Controlled Study of Tremelimumab for Second-Line and Third-Line Treatment of Unresectable Pleural or Peritoneal Mesothelioma
2014
·
A. Scherpereel
, R. Cornelissen
, et al.
·
Annals of Oncology
·
4
PDF
Adjuvant chemotherapy compared with observation in patients with resected biliary tract cancer: A systematic review and meta-analysis of randomized controlled trials
2025
·
Liying Tian
, Qian Guo
, et al.
·
PLoS ONE
·
3
PDF
Efficacy and safety profile of combining antiangiogenic agents with chemotherapy in patients with advanced malignant pleural mesothelioma: A systematic review and meta-analysis of randomized controlled trials
2023
·
Wei Tian
, Qian Guo
, et al.
·
PLoS ONE
·
1
PDF
ASS1 Promotes Colorectal Cancer Immune Evasion Through CPT1A-Mediated S100A10 Succinylation
2026
·
Liping Sun
, Daidi Fu
, et al.
·
Frontiers in Bioscience-Landmark
PDF
Show more works
View as search
Works count:
4
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type